Harbin Pharmaceutical Group Co., Ltd.SSE: 600664

Announcement on Abnormal Fluctuations in Stock Trading

Apr 16, 2026 · Issued by Harbin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 16, 2026

On 6ix: 6ix.com/news/announcement-on-abnormal-fluctuations-in-stock-trading-401

Announcement on Abnormal Fluctuations in Stock Trading

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Harbin Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Harbin Pharmaceutical

Announcement on Resolutions of the 24th Meeting of the 10th Board of DirectorsMar 10
Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic DrugsFeb 11
Announcement on Affiliated Enterprise Obtaining Approval for Marketing of Chemical APIsFeb 6
Announcement on Subsidiary Obtaining Drug Registration CertificateFeb 3
Announcement on Estimated Daily Related Party Transactions in 2026Jan 27

Later from Harbin Pharmaceutical

Announcement on Change of Accounting PoliciesApr 23
Announcement on Attending the Online Collective Reception Day for Investors of Listed Companies in Heilongjiang Jurisdiction in 2026 and the 2025 Annual and Q1 2026 Performance BriefingApr 30
Notice on Convening the 2025 Annual General MeetingJun 3
Announcement on Progress in Technology Transfer (Entrustment) Contract Signed by a Wholly-owned Subsidiary and Entry of Daprodustat Tablets into Phase III Clinical Trial (Confirmatory Clinical Study)Jun 11
Announcement on Resolutions of the 2025 Annual General MeetingJun 24

All Harbin Pharmaceutical news releases

Follow Harbin Pharmaceutical into a list and get an email when it puts out news.

Follow Harbin Pharmaceutical